In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Qiagen NV

www.qiagen.com

Latest From Qiagen NV

Global Device Approvals Snapshot: April 9-15, 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved Qiagen's therascreen FGFR RGQ RT-PCR companion diagnostic for Janssen's new drug to treat specific types of urothelial cancer and Intact Vascular's Tack device to treat dissections of the above-the-knee peripheral arteries following angioplasty.

Research & Development Approvals

FDA Approves Qiagen’s Therascreen Urothelial Cancer Companion Diagnostic

The Therascreen FGFR kit helps identify urothelial tumors with alterations to the fibroblast growth factor receptor 3 gene that indicate the cancer will respond to Janssen’s new drug Balversa.

Research & Development Approvals

Zimmer Biomet Wins US FDA Nod For Robotically Assisted Knee Replacement System

Zimmer Biomet announced 510 (k) clearance for its Rosa Knee system for robotically assisted total knee replacement surgery.

Approvals Orthopedics

Global Device Approvals, Weekly Snapshot: A Quiet Period

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker.

Approvals Research & Development
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register